Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)

Clinical trial NCT04971161 · COMPLETED

Trial details

NCT number: NCT04971161
Sponsor: RHEACELL GmbH & Co. KG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Skin Ulcer Venous Stasis Chronic

Start date: 2021-08-18
Primary completion: 2025-11-25
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.